By Chandrayee Roy Choudhury, Canada:
A Calgary- Drug designed to reduce organ inflammation in CoVid -19 patients is entering a national human trial , with a study into its effectiveness set to begin at 65 hospitals across CANADA.
Being a part of the National Trial means data will soon be available that can determine whether METABLOK is a viable treatment for CoVid19 , according to Dr. DAN MURUVE, the company's chief Science Officer
/anm-english/media/agency_attachments/AtBG5e3MoE629QYzhZen.png)
/ )
/anm-english/media/post_banners/ranyCGz5cpF4Kg2RMfkD.jpg)